ProKidney Stock (NASDAQ: PROK) stock price, news, charts, stock research, profile.
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Other companies in ProKidney’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL), Inozyme Pharma (NASDAQ:INZY) and Larimar Therapeutics (NASDAQ:LRMR).
ProKidney has a consensus price target of $10.13.
The stock price for ProKidney (NASDAQ: PROK) is $1.77 last updated January 3, 2025 at 4:00 PM EST.
There are no upcoming dividends for ProKidney.
ProKidney’s Q4 earnings are confirmed for Friday, March 21, 2025.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.